Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss attributable to New Relic	$ (250,402)	$ (192,610)	$ (88,937)
Net loss and adjustment attributable to redeemable non-controlling interest (Note 3)	18,297	1,720	(2,042)
Net loss:	(232,105)	(190,890)	(90,979)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	86,065	89,312	75,743
Stock-based compensation expense	153,039	135,143	99,536
Amortization of debt discount and issuance costs	2,357	22,336	21,107
Gain on lease modification	0	0	(3,006)
Other	1,429	3,610	(1,399)
Changes in operating assets and liabilities, net of acquisition of businesses:
Accounts receivable, net	(53,319)	(27,084)	(28,425)
Prepaid expenses and other assets	(5,796)	(7,571)	760
Deferred contract acquisition costs	(2,345)	(46,953)	(39,505)
Lease right-of-use assets	8,294	959	21,751
Accounts payable	9,745	11,766	7,436
Accrued compensation and benefits and other liabilities	19,564	18,778	5,044
Lease liabilities	(6,898)	1,519	(19,374)
Deferred revenue	23,594	58,941	44,730
Net cash provided by operating activities	3,624	69,866	93,419
Cash flows from investing activities:
Purchases of property and equipment	(5,778)	(18,737)	(58,218)
Proceeds from sale of property and equipment	1,001	0	0
Cash paid for acquisitions, net of cash acquired	(7,192)	(41,536)	(4,250)
Purchases of short-term investments	(301,068)	(405,054)	(391,079)
Proceeds from sale and maturity of short-term investments	305,942	335,964	395,559
Capitalized software development costs	(12,662)	(13,494)	(6,641)
Net cash used in investing activities	(19,757)	(142,857)	(64,629)
Cash flows from financing activities:
Investment from redeemable non-controlling interest	0	0	978
Proceeds from employee stock purchase plan	12,272	14,425	13,603
Proceeds from exercise of employee stock options	31,868	6,865	11,632
Net cash provided by financing activities	44,140	21,290	26,213
Net increase (decrease) in cash, cash equivalents and restricted cash	28,007	(51,701)	55,003
Cash, cash equivalents and restricted cash at beginning of period	246,463	298,164	243,161
Cash, cash equivalents and restricted cash at end of period	274,470	246,463	298,164
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets:
Cash and cash equivalents	268,695	240,821	292,523
Restricted cash	5,775	5,642	5,641
Total cash, cash equivalents and restricted cash	274,470	246,463	298,164
Supplemental disclosure of cash flow information:
Cash paid for interest and income taxes	4,666	4,544	4,184
Noncash investing and financing activities:
Issuance of common stock for the acquisition of business	13,487	62,365	0
Property and equipment purchased but not paid yet	8	1,776	2,196
Acquisition holdback	$ 7,250	$ 0	$ 850